David Adelman Email & Phone Number

Irvine, Ca, Us

Irvine, California, United States

Lead both global strategy development and execution for the TMTT business unit dedicated to leading and transforming treatment for patients with mitral and tricuspid valve disease.

Nyon, Switzerland

Created and led a strategy function with a focus on launching breakthrough innovations in the structural heart disease space; assumed interim responsibility for the Market Access team including Reimbursement, Healthcare Economics, Public Affairs and Public Relations.

Irvine, California

Created a new service business model by developing, piloting and commercializing programs that improve patient access to structural heart disease care and meet the needs of the provider system executive

Irvine, Ca

General Management responsibility for a $400M portfolio of acute care products that includes mature, market leading brands and newer, minimally invasive monitoring modalities. Refocused mature product lines for growth and profitability. Remediated compliance risk to establish a solid platform of product engineering and documentation for future growth.

General Management responsibility for $300M business of high growth, innovative products and mature brands; included capital equipments and single use products. Developed and executed an Enhanced Surgical Recovery growth strategy that integrated products with therapeutic protocols into a healthcare solution that reduced complications and cost in high-risk surgery. Led a surgeon-focused sales and marketing strategy to augment established strength with the anesthesiologist and intensivist communities.

Developed corporate strategy by leading the annual strategic planning process in partnership with the Executive Leadership Team and the Board of Directors. Revamped the company’s strategy execution management process to clearly identify near-term strategic imperatives and align organizational priorities, individual objectives and bonus compensation. Led numerous internal consulting deep dive projects that drove strategic decisions

Led a $50M portfolio of cardiac surgery products achieving double digit revenue growth. Exceeded market share goals by executing a sales strategy focused on share protection to counter a major competitive market entrance. Restructured the product portfolio to improve focus, competitive posture and profitability by exiting several product lines including ventricular assist devices; implemented corresponding organization realignment

Led a $100M portfolio of acute care products. Restructured the product portfolio to focus on market leading, differentiated products by existing distributed product lines including Medtronic cardiac rhythm management and Datascope intra-aortic balloons.

Led global $250M Critical Care franchise, the global leader in hemodynamic monitoring products for the anesthesiology and intensivist markets. Initiated new product development programs to identify and pursue growth opportunities in minimally invasive monitoring modalities and vascular access

Identified strategic alternatives for the business unit and vetted potential acquirers. Successfully negotiated and executed the sale of the division including global sales and manufacturing

Led strategy development for three $100+M divisions. Managed interdisciplinary due diligence teams

Master'S Degree, International Economics & Affairs, Japan Studies, Toyota Fellow

Bachelor'S Degree, Economics, Public Policy Studies, Honors: Cum Laude, Dean’S List, Class Honors

Degree Related Internships: • The Brookings Institution, Summer 1985 • Omron Corporation, Summer 1986

Education record

Undergraduate and graduate level course work in developmental economics